Marklund Niklas
Division of Neurosurgery, Department of Neuroscience, Uppsala University Hospital, Uppsala University, Uppsala, 751 85, Sweden.
Methods Mol Biol. 2016;1462:29-46. doi: 10.1007/978-1-4939-3816-2_3.
Traumatic brain injury (TBI) has been named the most complex disease in the most complex organ of the body. It is the most common cause of death and disability in the Western world in people <40 years old and survivors commonly suffer from persisting cognitive deficits, impaired motor function, depression and personality changes. TBI may vary in severity from uniformly fatal to mild injuries with rapidly resolving symptoms and without doubt, it is a markedly heterogeneous disease. Its different subtypes differs in their pathophysiology, treatment options and long-term consequences and to date, there are no pharmacological treatments with proven clinical benefit available to TBI patients. To enable development of novel treatment options for TBI, clinically relevant animal models are needed. Due to their availability and low costs, numerous rodent models have been developed which have substantially contributed to our current understanding of the pathophysiology of TBI. The most common animal models used in laboratories worldwide are likely the controlled cortical impact (CCI) model, the central and lateral fluid percussion injury (FPI) models, and weight drop/impact acceleration (I/A) models. Each of these models has inherent advantages and disadvantages; these need to be thoroughly considered when selecting the rodent TBI model according to the hypothesis and design of the study. Since TBI is not one disease, refined animal models must take into account the clinical features and complexity of human TBI. To enhance the possibility of establishing preclinical efficacy of a novel treatment, the preclinical use of several different experimental models is encouraged as well as varying the species, gender, and age of the animal. In this chapter, the methods, limitations, and challenges of the CCI and FPI models of TBI used in rodents are described.
创伤性脑损伤(TBI)被认为是人体最复杂器官中最复杂的疾病。它是西方世界40岁以下人群死亡和残疾的最常见原因,幸存者通常患有持续的认知缺陷、运动功能受损、抑郁和性格改变。TBI的严重程度可能从一致致命到症状迅速缓解的轻度损伤不等,毫无疑问,它是一种明显异质性的疾病。其不同亚型在病理生理学、治疗选择和长期后果方面存在差异,迄今为止,尚无已证实对TBI患者有临床益处的药物治疗方法。为了开发针对TBI的新型治疗方案,需要具有临床相关性的动物模型。由于其可得性和低成本,已经开发了许多啮齿动物模型,这些模型为我们目前对TBI病理生理学的理解做出了重大贡献。全球实验室中最常用的动物模型可能是控制性皮质撞击(CCI)模型、中心和侧方液压冲击伤(FPI)模型以及重物下落/撞击加速(I/A)模型。这些模型中的每一个都有其固有的优点和缺点;在根据研究的假设和设计选择啮齿动物TBI模型时,需要充分考虑这些因素。由于TBI不是一种单一的疾病,精细的动物模型必须考虑人类TBI的临床特征和复杂性。为了提高建立新型治疗临床前疗效的可能性,鼓励在临床前使用几种不同的实验模型,并改变动物的物种、性别和年龄。在本章中,将描述啮齿动物中使用的TBI的CCI和FPI模型的方法、局限性和挑战。